The second indigenous CAR-T cell therapy, Qartemi, has been approved by India's drug regulator. Qartemi is a "living drug" ...

Clinical trial applications in India are taking a step forward, with the approval of a Central Drugs Standard Control ... use the system to enable the CDSCO to process applications in an efficient ...

CDSCO seeks urgent industry inputs on regulatory challenges and innovation in pharma: Shardul Nautiyal, Mumbai Thursday, January 23, 2025, 08:00 Hrs [IST] The Central Drugs Standa ...

New Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has ...

Drugmaker Wockhardt on Thursday announced Central Drugs Standard Control Organization (CDSCO) approval for use of ... plans to launch Miqnaf in the Indian market in coming few months, Wockhardt ...

MannKind (MNKD) and Cipla announced that the Central Drugs Standard Control Organisation in India has approved Afrezza Inhalation Powder in adults. The CDSCO decision follows existing approvals in ...

As the government continues its search for a new Drugs Controller General of India (DCGI), it has decided to extend the ...

The CDSCO, which is the apex body responsible for approval of new drugs and clinical trials, has issued an alert regarding this. According to latest data, they found 41 batches of drugs ...

The Central Drugs Standard Control Organisation (CDSCO) has banned the import of refurbished medical devices, reinforcing India’s commitment to patient safety and strengthening the local industry's ...

and Cipla Ltd. announced today that the Central Drugs Standard Control Organisation (CDSCO) in India has approved Afrezza (insulin human) Inhalation Powder in adults. The CDSCO decision follows ...